0000950170-24-023495.txt : 20240229 0000950170-24-023495.hdr.sgml : 20240229 20240229212544 ACCESSION NUMBER: 0000950170-24-023495 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240227 FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bylund James CENTRAL INDEX KEY: 0001849642 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 24706595 MAIL ADDRESS: STREET 1: C/O REPLIGEN CORPORATION STREET 2: 41 SYON ST. BLDG. SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 ownership.xml 4 X0508 4 2024-02-27 0000730272 REPLIGEN CORP RGEN 0001849642 Bylund James C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 false true false false Chief Operating Officer false Common Stock 2024-02-27 4 A false 8691 0.00 A 22826 D Stock Option (Right to Buy) 192.71 2024-02-27 4 A false 8632 0.00 A 2034-02-27 Common Stock 8632 8632 D Mr. Bylund was awarded 8,691 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026 and February 27, 2027. /s/ Kimberly Brown (Attorney in Fact) 2024-02-29